Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Fibromyalgia HELP
Based on 3,337 articles since 2008
||||

These are the 3337 published articles about Fibromyalgia that originated from Worldwide during 2008-2017.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline [Guidelines for the diagnosis and treatment of the fibromyalgia syndrome]. 2013

Ablin, Jacob N / Amital, Howard / Ehrenfeld, Michael / Aloush, Valerie / Elkayam, Ori / Langevitz, Pnina / Mevorach, Dror / Mader, Reuven / Sachar, Tali / Amital, Daniela / Buskila, Dan / Anonymous5450783. ·Institute of Rheumatotogy, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel. · Department of Medicine B, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Israel. · Rheumatalogy Unit, Sheba Medical Center, Tel-Hashomer, the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · The Laboratory for Cevlular and Molecular Immunology, Department of Medicine, Rheumatology Research Center, Hadassah-Hebrew University Medical Center, Jerusalem. Israel. · Rheumatic Diseases Unit, Ha'Emek Medical Center, Afula, Israel. · Family Medicine Department, Hebrew University, Jerusalem, Israel. · Department of Psychiatry 'B, Ness Ziona Mental Health Center, Ness Ziona, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Medicine H, Soroka Medical Center and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel. · ·Harefuah · Pubmed #24483001.

ABSTRACT: Over the past years, considerable progress has been made in understanding the pathogenesis of the fibromyatgia syndrome and the evidence based approach to the diagnosis and management has been significantty extended. The purpose of the current project is to develop practicat and evidence based guidetine recommendations for the Israeli health care system. A panet of physicians with clinical and research experience in the fibromyalgia field was convened under the auspices of the Israeli Rheumatology Association. A systematic review was performed on the current literature regarding the diagnosis and treatment of fibromyalgia. Using an interactive discussion procedure, recommendations were reached and expert opinion was introduced where evidence was considered incomplete. The panel recommendations underline the importance of concomitant and integrated medical therapy, such as serotonin and noradrenaline reuptake inhibitor (SNRI) anti-depressants or gamma-aminobutyric acid (GABA) related anti-epileptics, with regular aerobic physical exercise.

2 Guideline 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. 2013

Fitzcharles, Mary-Ann / Ste-Marie, Peter A / Goldenberg, Don L / Pereira, John X / Abbey, Susan / Choinière, Manon / Ko, Gordon / Moulin, Dwight E / Panopalis, Pantelis / Proulx, Johanne / Shir, Yoram / Anonymous5120760. ·Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada. mary-ann.fitzcharles@muhc.mcgill.ca · ·Pain Res Manag · Pubmed #23748251.

ABSTRACT: BACKGROUND: Recent neurophysiological evidence attests to the validity of fibromyalgia (FM), a chronic pain condition that affects >2% of the population. OBJECTIVES: To present the evidence-based guidelines for the diagnosis, management and patient trajectory of individuals with FM. METHODS: A needs assessment following consultation with diverse health care professionals identified questions pertinent to various aspects of FM. A literature search identified the evidence available to address these questions; evidence was graded according to the standards of the Oxford Centre for Evidence-Based Medicine. Drafted recommendations were appraised by an advisory panel to reflect meaningful clinical practice. RESULTS: The present recommendations incorporate the new clinical concepts of FM as a clinical construct without any defining physical abnormality or biological marker, characterized by fluctuating, diffuse body pain and the frequent symptoms of sleep disturbance, fatigue, mood and cognitive changes. In the absence of a defining cause or cure, treatment objectives should be patient-tailored and symptom-based, aimed at reducing global complaints and enhancing function. Healthy lifestyle practices with active patient participation in health care forms the cornerstone of care. Multimodal management may include nonpharmacological and pharmacological strategies, although it must be acknowledged that pharmacological treatments provide only modest benefit. Maintenance of function and retention in the workforce is encouraged. CONCLUSIONS: The new Canadian guidelines for the treatment of FM should provide health professionals with confidence in the complete care of these patients and improve clinical outcomes.

3 Guideline [Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline]. 2012

Zernikow, B / Gerhold, K / Bürk, G / Häuser, W / Hinze, C H / Hospach, T / Illhardt, A / Mönkemöller, K / Richter, M / Schnöbel-Müller, E / Häfner, R / Anonymous11590730. ·Deutsches Kinderschmerzzentrum, Vestische Kinder- und Jugendklinik, Universität Witten/Herdecke, Dr.-Friedrich-Steiner-Str. 5, 45711, Datteln, Deutschland. b.zernikow@deutsches-kinderschmerzzentrum.de · ·Schmerz · Pubmed #22760465.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The diagnosis FMS in children and adolescents is not established. In so-called juvenile FMS (JFMS) multidimensional diagnostics with validated measures should be performed. Multimodal therapy is warranted. In the case of severe pain-related disability, therapy should be primarily performed on an inpatient basis. The English full-text version of this article is available at SpringerLink (under "Supplemental").

4 Guideline [Complementary and alternative therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Langhorst, J / Häuser, W / Bernardy, K / Lucius, H / Settan, M / Winkelmann, A / Musial, F / Anonymous11580730. ·Innere Medizin V (Naturheilkunde und Integrative Medizin), Kliniken Essen-Mitte, Am Deimelsberg 34a, 45276, Essen, Deutschland. j.langhorst@kliniken-essen-mitte.de · ·Schmerz · Pubmed #22760464.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The recommendations were based on level of evidence, efficacy (meta-analysis of the outcomes pain, sleep, fatigue and health-related quality of life), acceptability (total dropout rate), risks (adverse events) and applicability of treatment modalities in the German health care system. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Meditative movement therapies (qi gong, tai chi, yoga) are strongly recommended. Acupuncture can be considered. Mindfulness-based stress reduction as monotherapy and dance therapy as monotherapy are not recommended. Homeopathy is not recommended. In a minority vote, homeopathy was rated as "can be considered". Nutritional supplements and reiki are not recommended. The English full-text version of this article is available at SpringerLink (under "Supplemental").

5 Guideline [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Sommer, C / Häuser, W / Alten, R / Petzke, F / Späth, M / Tölle, T / Uçeyler, N / Winkelmann, A / Winter, E / Bär, K J / Anonymous11570730. ·Neurologische Klinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Deutschland. sommer@uni-wuerzburg.de · ·Schmerz · Pubmed #22760463.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The recommendations were based on level of evidence, efficacy (meta-analysis of the outcomes pain, sleep, fatigue and health-related quality of life), acceptability (total dropout rate), risks (adverse events) and applicability of treatment modalities in the German health care system. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Amitriptyline and-in case of comorbid depressive disorder or generalized anxiety disorder-duloxetine are recommended. Off-label use of duloxetine and pregabalin can be considered in case of no comorbid mental disorder. Strong opioids are not recommended. The English full-text version of this article is available at SpringerLink (under "Supplemental").

6 Guideline [Psychotherapy for patients with fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Köllner, V / Häuser, W / Klimczyk, K / Kühn-Becker, H / Settan, M / Weigl, M / Bernardy, K / Anonymous11560730. ·Fachklinik für Psychosomatische Medizin, MediClin Bliestal Kliniken, Am Spitzenberg, 66440, Blieskastel, Deutschland. volker.koellner@mediclin.de · ·Schmerz · Pubmed #22760462.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The recommendations were based on level of evidence, efficacy (meta-analysis of the outcomes pain, sleep, fatigue and health-related quality of life), acceptability (total dropout rate), risks (adverse events) and applicability of treatment modalities in the German health care system. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Cognitive behavioral therapy combined with aerobic exercise (multicomponent therapy) is strongly recommended. Relaxation as single therapy should not be applied. The English full-text version of this article is available at SpringerLink (under "Supplemental").

7 Guideline [Multicomponent therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Arnold, B / Häuser, W / Arnold, M / Bernateck, M / Bernardy, K / Brückle, W / Friedel, E / Hesselschwerdt, H J / Jäckel, W / Köllner, V / Kühn, E / Petzke, F / Settan, M / Weigl, M / Winter, E / Offenbächer, M / Anonymous11550730. ·Abteilung für Schmerztherapie, Klinikum Dachau, Krankenhausstr. 15, 85221, Dachau, Deutschland. bernhard.arnold@amperkliniken.de · ·Schmerz · Pubmed #22760461.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The use of a multicomponent therapy (the combination of aerobic exercise with at least one psychological therapy) for a minimum of 24 h is strongly recommended for patients with severe FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").

8 Guideline [Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Winkelmann, A / Häuser, W / Friedel, E / Moog-Egan, M / Seeger, D / Settan, M / Weiss, T / Schiltenwolf, M / Anonymous11540730. ·Klinik und Poliklinik für Physikalische Medizin und Rehabilitation, Klinikum der Universität München, Ziemssenstr. 1, 80336, München, Deutschland. andreas.winkelmann@med.uni-muenchen.de · ·Schmerz · Pubmed #22760460.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Low-to-moderate intensity aerobic exercise and strength training are strongly recommended. Chiropractic, laser therapy, magnetic field therapy, massage and transcranial current stimulation are not recommended. The English full-text version of this article is available at SpringerLink (under "Supplemental").

9 Guideline [Fibromyalgia syndrome. General principles and coordination of clinical care and patient education]. 2012

Eich, W / Häuser, W / Arnold, B / Bernardy, K / Brückle, W / Eidmann, U / Klimczyk, K / Köllner, V / Kühn-Becker, H / Offenbächer, M / Settan, M / von Wachter, M / Petzke, F / Anonymous11530730. ·Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 10, 69210, Heidelberg, Deutschland. wolfgang.eich@med.uni-heidelberg.de · ·Schmerz · Pubmed #22760459.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: A diagnosis of FMS should be explicitly communicated with the afflicted individual. A step-wise treatment, depending on the severity of FMS and the responses to therapeutic measures, is recommended. Therapy should only be continued if the positive effects outweigh the side effects. The English full-text version of this article is available at SpringerLink (under "Supplemental").

10 Guideline [Etiology and pathophysiology of fibromyalgia syndrome]. 2012

Sommer, C / Häuser, W / Burgmer, M / Engelhardt, R / Gerhold, K / Petzke, F / Schmidt-Wilcke, T / Späth, M / Tölle, T / Uçeyler, N / Wang, H / Winkelmann, A / Thieme, K / Anonymous11520730. ·Neurologische Klinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Deutschland. sommer@uni-wuerzburg.de · ·Schmerz · Pubmed #22760458.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. RESULTS: Current data do not identify distinct etiologic or pathophysiological factors mediating development of FMS. The development of FMS is associated with inflammatory rheumatic diseases (EL2b), with gene polymorphisms of the 5-hydroxytryptamine (HT)(2) receptor (EL3a), lifestyle factors (smoking, obesity, lack of physical activity; EL2b), physical and sexual abuse in childhood and adulthood (EL3a). CONCLUSION: FMS is most likely the result of various pathogenetic factors and pathophysiological mechanisms. The English full-text version of this article is available at SpringerLink (under "Supplemental").

11 Guideline [Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis]. 2012

Eich, W / Häuser, W / Arnold, B / Jäckel, W / Offenbächer, M / Petzke, F / Schiltenwolf, M / Settan, M / Sommer, C / Tölle, T / Uçeyler, N / Henningsen, P / Anonymous11510730. ·Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 10, 69210, Heidelberg, Deutschland. wolfgang.eich@med.uni-heidelberg.de · ·Schmerz · Pubmed #22760457.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The clinical diagnosis of FMS can be established by the American College of Rheumatology (ACR) 1990 classification criteria (with tender point examination), by the modified preliminary diagnostic ACR 2010 criteria or by the diagnostic criteria of the German interdisciplinary guideline (AWMF) on FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").

12 Guideline Interdisciplinary consensus document for the treatment of fibromyalgia. 2010

de Miquel, C Alegre / Campayo, J García / Flórez, M Tomás / Arguelles, J M Gómez / Tarrio, E Blanco / Montoya, M Gobbo / Martin, Á Pérez / Salio, A Martínez / Fuentes, J Vidal / Alberch, E Altarriba / de la Cámara, A Gómez. ·Jefe de Servicio de ReumatologíaHospital Universitari Val d’HebrónBarcelona, Spain. · ·Actas Esp Psiquiatr · Pubmed #21361054.

ABSTRACT: Backgrounds. The elevated prevalence and enormous clinical and social impact of fibromyalgia, together with the complexity of its treatment, require action consensuses that guide health care professionals. Although there are some similar documents in our language, most have been made from the perspective of a single discipline.Objective. To develop a consensus on the treatment of fibromyalgia made by selected representatives and supported by the principal medical associations that intervene in its treatment (rheumatology, neurology, psychiatry,rehabilitation and family medicine) and representatives of the associations of patients. On the other hand, understanding the disease not as a homogenous disorders but also as the sum of different clinical subtypes,having specific symptomatic characteristics and different therapeutic needs is stressed. This approach represented a need perceived by the clinicians and a novelty regarding previous consensuses.Methods. The different clinical classifications proposed in fibromyalgia and the scientific evidence of the treatments used in this disease were reviewed. For the selection of the classification used and performance of the therapeutic recommendations, some of the usual techniques to obtain the consensus (nominal group and brainstorming) were used.Conclusion. The classification of Giesecke of fibromyalgia into 3 subgroups seems to have the greatest scientific evidence and the most useful for the clinician. The guide offers a series of general recommendations for all the patients with fibromyalgia. However, in addition, for each subgroup, there are a series of specific pharmacological and psychological-type recommendations and those of modification of the environment, which will make it possible to have a personalized approach to the patient with fibromyalgia in accordance with their individual clinical characteristics (pain, catastrophizing levels, etc.).

13 Guideline [Definition, classification and diagnosis of fibromyalgia syndrome]. 2008

Eich, W / Häuser, W / Friedel, E / Klement, A / Herrmann, M / Petzke, F / Offenbächer, M / Schiltenwolf, M / Sommer, C / Tölle, T / Henningsen, P. ·Abteilung Innere Medizin II, Universitatsklinikum Heidelberg, Heidelberg. wolfgang.eich@med.uni-heidelberg.de · ·Z Rheumatol · Pubmed #19050952.

ABSTRACT: BACKGROUND: Interdisciplinary guidelines for the definition, classification and diagnosis of chronic widespread pain (CWP) and fibromyalgia syndrome (FMS) were developed by collaboration of 10 German medical and psychological associations and 2 patient self-help organizations. METHODS: A systematic literature search was performed in the Cochrane Library (1993-12/2006). Medline (1980-2006), and Scopus (1980-12/2006). Levels of evidence were assigned according to the classification system of the Oxford Center for Evidence-Based Medicine. Grading of the strength of recommendation was done according to the German program for disease management guidelines. Standardized procedures to reach a consensus on recommendations were used. RESULTS: CWP is defined by the criteria of the American College of Rheumatology (ACR-strong consensus). FMS can be diagnosed for clinical purposes by symptom-based criteria (without tender point examination) as well as by the ACR criteria (strong consensus).

14 Guideline [S3 guideline of AWMF--definition, pathophysiology, diagnosis and therapy of fibromyalgia syndrome]. 2008

Anonymous6340602. · ·Z Orthop Unfall · Pubmed #18600620.

ABSTRACT: -- No abstract --

15 Guideline [Definition, classification and diagnosis of fibromyalgia syndrome]. 2008

Eich, W / Häuser, W / Friedel, E / Klement, A / Herrmann, M / Petzke, F / Offenbächer, M / Schiltenwolf, M / Sommer, C / Tölle, T / Henningsen, P. ·Abteilung Innere Medizin II (Allgemeine Klinische und Psychosomatische Medizin), Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69210, Heidelberg. wolfgang.eich@med.uni-heidelberg.de · ·Schmerz · Pubmed #18478271.

ABSTRACT: BACKGROUND: Interdisciplinary guidelines for the definition, classification and diagnosis of chronic widespread pain (CWP) and fibromyalgia syndrome (FMS) were developed by collaboration of 10 German medical and psychological associations and 2 patient self-help organizations. METHODS: A systematic literature search was performed in the Cochrane Library (1993-12/2006), Medline (1980-2006), PsychInfo (1966-12/2006), and Scopus (1980-12/2006). Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. Grading of the strength of recommendation was done according to the German program for disease management guidelines. Standardized procedures to reach a consensus on recommendations were used. RESULTS: CWP is defined by the criteria of the American College of Rheumatology (ACR--strong consensus). FMS can be diagnosed for clinical purposes by symptom-based criteria (without tender point examination) as well as by the ACR criteria (strong consensus).

16 Guideline [Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain]. 2008

Klement, A / Häuser, W / Brückle, W / Eidmann, U / Felde, E / Herrmann, M / Kühn-Becker, H / Offenbächer, M / Settan, M / Schiltenwolf, M / von Wachter, M / Eich, W. ·Institut für Allgemeinmedizin, Martin-Luther-Universität Halle-Wittenberg, 06112 Halle. andreas.klement@medizin.uni-halle.de · ·Schmerz · Pubmed #18478270.

ABSTRACT: BACKGROUND: A guideline for the treatment and diagnostic procedures for fibromyalgia syndrome (FMS) was developed in cooperation with 10 German medical and psychological associations and 2 patient self-help groups. METHODS: A systematic literature search including all controlled studies evaluating physiotherapy, exercise and strength training as well as physical therapies was performed in the Cochrane Collaboration Reviews (1993-12/2006), Medline (1980-12/2006), PsychInfo (1966-12/2006) and Scopus (1980-12/2006). Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. Grading of the strengths of recommendations was done according to the German program for disease management guidelines. Standardized procedures to reach a consensus on recommendations were used. RESULTS: Patient's information at first diagnosis of FMS is strongly recommended (grade A). Patient-centered communication is recommended (grade B). A stepwise treatment approach depending on the adapatation to restrictions in daily life and response to treatment options can be considered (grade C). CONCLUSIONS: The long-term treatment should be based on principles of basic psychosomatic care and shared decision making on treatment options.

17 Guideline [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain]. 2008

Sommer, C / Häuser, W / Gerhold, K / Joraschky, P / Petzke, F / Tölle, T / Uçeyler, N / Winkelmann, A / Thieme, K. ·Neurologische Klinik, Universität Würzburg, Würzburg. sommer@mail.uni-wuerzburg.de · ·Schmerz · Pubmed #18470541.

ABSTRACT: OBJECTIVE: To write a systematic review on the etiology and pathophysiology of the fibromyalgia syndrome (FMS) and of chronic widespread pain (CWP). METHODS: An interdisciplinary level-3 guideline (i.e. systematic literature search and assessment, logic analysis, formal consensus procedure) for the diagnosis and therapy of FMS was created in cooperation with 10 medical and psychological societies and 2 patient self-help organizations. A literature search was performed covering all available review articles on the etiology and pathophysiology of FMS and CWP using the Cochrane Collaboration Reviews (1993-12/2006), Medline (1980-2006), PsychInfo (1966-12/2006), and Scopus (1980-12/2006). For the assignment of evidence classes the system of the Oxford Centre for Evidence-Based Medicine was applied. Consensus was achieved by a multi-step nominal group procedure. RESULTS: FMS aggregates in families (evidence level 2c). Physical and psychological stress at the workplace are risk factors for the development of CWP and FMS. Affective disorders are risk factors for the development and maintenance of FMS. Operant learning mechanisms and sensitization are risk factors for the chronification of FMS (evidence levels 2b). Several factors are associated with the pathophysiology of FMS, but the causal relationship is unclear. This includes alterations of central pain pathways, hyporeactivity of the hypothalamus-pituitary-adrenal axis, increased systemic pro-inflammatory and reduced anti-inflammatory cytokine profiles and disturbances in the dopaminergic and serotonergic systems. CONCLUSIONS: FMS is the common final product of various etiological factors and pathophysiological mechanisms.

18 Guideline [Juvenile fibromyalgia syndrome]. 2008

Michels, H / Gerhold, K / Häfner, R / Häuser, W / Illhardt, A / Mönkemöller, K / Richter, M / Schuchmann, L. ·Deutsches Zentrum für Kinder- und Jugendrheumatologie, Gehfeldstrasse 24, 82467, Garmisch-Partenkirchen. michels.hartmut@rummelsberger.net · ·Schmerz · Pubmed #18470540.

ABSTRACT: OBJECTIVE: The aim was to develop a guideline for diagnostic procedures and treatment of juvenile fibromyalgia syndrome (JFMS) in cooperation with 10 German medical and psychological associations and 2 patient self-help groups. METHODS: A systematic literature search, including all controlled studies evaluating diagnosis and treatment of JFMS, was performed in the Cochran Collaboration Reviews (1993-12/2006), Medline (1980-12/2006), PsychInfo (1966-12/2006) and Scopus (1980-12/2006). Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. Grading of the strengths of recommendations was performed according to the German program for disease management guidelines. Standardized procedures to reach a consensus on recommendations were used. RESULTS: Pain in children/adolescents involving several body areas and lasting >3 months without an obvious somatic cause is called JFMS or pain amplification syndrome. Therapeutically, a multidisciplinary concept with psychotherapy and physiotherapy, relaxation techniques and patient education is recommended. CONCLUSION: These guideline will contribute to a better recognition and standardized care of patients with JFMS and facilitate clinical studies.

19 Guideline [Alternative and complementary therapies in fibromyalgia syndrome]. 2008

Langhorst, J / Häuser, W / Irnich, D / Speeck, N / Felde, E / Winkelmann, A / Lucius, H / Michalsen, A / Musial, F. ·Klinik für Innere Medizin V, Naturheilkunde und Integrative Medizin, Kliniken Essen-Mitte, Am Deimelsberg 34a, 45276 Essen. jost.langhorst@gmx.de · ·Schmerz · Pubmed #18463899.

ABSTRACT: INTRODUCTION: Interdisciplinary S3 level guidelines were devised in cooperation with 8 medical, 2 psychological and 2 patient support groups. Results were elaborated in a multilevel group process. METHODS: On the bases of the "Cochrane Library" (1993-2006), "Medline" (1980-2006), "PsychInfo" (2006) and "Scopus" (2006) controlled studies and meta-analyses of controlled studies were analyzed. RESULTS: Only few controlled studies were found supporting in part the effectiveness of CAM therapies in the treatment of fibromyalgia syndrome. Due to the lack of information on long term efficacy and cost-effectiveness, only limited recommendations for CAM therapies can be given. CONCLUSION: Within a multicomponent therapy setting, selective CAM therapies (acupuncture, vegetarian diet, homeopathy, Tai Chi, Qi Gong, music-oriented and body-oriented therapies) can be recommended for a limited period of time.

20 Guideline [Multicomponent therapy for treatment of fibromyalgia syndrome]. 2008

Arnold, B / Häuser, W / Bernardy, K / Brückle, W / Friedel, E / Köllner, V / Kühn-Becker, H / Richter, M / Weigl, M / Weiss, T / Offenbächer, M. ·Abteilung für Schmerztherapie, Klinikum Dachau, Krankenhausstr. 15, 85221, Dachau. bernhard.arnold@amperkliniken.de · ·Schmerz · Pubmed #18463898.

ABSTRACT: BACKGROUND: A guideline for the treatment of fibromyalgia syndrome (FMS) was developed in cooperation with 10 German medical and psychological associations and 2 patient self-help groups. METHODS: A systematic literature search including all controlled studies evaluating multicomponent therapy (MT) was performed in the Cochrane Library (1993-12/2006), Medline (1980-12/2006), PsychInfo (1966-12/2006) and Scopus (1980-12/2006). Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. Grading of the strengths of recommendations was done according to the German program for disease management guidelines. Standardized procedures to reach a consensus on recommendations were used. RESULTS: MT is superior to control groups or routine treatment (evidence level 1A) and should be offered to FMS patients (recommendation strength A). CONCLUSIONS: Future studies should consider medication, other co-therapies and comorbidities. MT programs tailored to FMS subgroups should be tested.

21 Guideline [Psychotherapy in patients with fibromyalgia syndrome]. 2008

Thieme, K / Häuser, W / Batra, A / Bernardy, K / Felde, E / Gesmann, M / Illhardt, A / Settan, M / Wörz, R / Köllner, V. ·Institut für Neuropsychologie und Klinische Psychologie, Zentralinstitut für Seelische Gesundheit Mannheim, Universität Heidelberg , J5, 68159 Mannheim. thieme@zi-mannheim.de · ·Schmerz · Pubmed #18458959.

ABSTRACT: BACKGROUND: A guideline for the treatment and diagnostic procedures in fibromyalgia syndrome (FMS) was developed in cooperation with 10 German medical and psychological associations and 2 patient self-help groups. METHODS: A systematic literature search including all controlled studies of evaluated multicomponent therapy was performed in the Cochrane Collaboration Reviews (1993-12/2006), Medline (1980-12/2006), PsychInfo (1966-12/2006) and Scopus (1980-12/ 2006). Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. Grading of the strengths of recommendations was done according to the German program for disease management guidelines. Standardized procedures to reach a consensus on recommendations were used. RESULTS: Cognitive and operant behavioral therapy is strongly recommended (grade A). Guided imagery/hypnotherapy and written emotional disclosure are recommended (grade B). CONCLUSIONS: Psychotherapeutic programs tailored to FMS subgroups should be developed and tested.

22 Guideline [Pharmacological treatment of fibromyalgia syndrome]. 2008

Sommer, C / Häuser, W / Berliner, M / Brückle, W / Ehlers, S / Mönkemöller, K / Moradi, B / Petzke, F / Uçeyler, N / Wörz, R / Winter, E / Nutzinger, D O. ·Neurologische Klinik, Universität Würzburg, Würzburg. sommer@mail.uni-wuerzburg.de · ·Schmerz · Pubmed #18458958.

ABSTRACT: BACKGROUND: An interdisciplinary guideline for the treatment of fibromyalgia syndrome (FMS) and chronic widespread pain (CWP) was developed in cooperation with ten German medical and psychological associations and two patients' self-help organizations. METHODS: Using the Cochrane Collaboration Reviews (1993-12/2006), Medline (1980-2006), PsychInfo (1966-12/2006), and Scopus (1980-12/ 2006) a systematic literature search was performed, which included all randomised controlled trials (RCT) evaluating multicomponent therapy in FMS and CWP. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. The strength of recommendation was graded according to the German program for disease management guidelines. Consensus was achieved using a multi-step nominal group procedure. RESULTS: The short-term use of amitriptyline is strongly recommended (grade A) and the short-term use of fluoxetine und duloxetine is recommended (grade B). CONCLUSIONS: The recommendations regarding pharmacological treatment of FMS are limited by the short duration of the RCT, the lack of follow-ups and absence of cost-effectiveness studies.

23 Guideline [Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome]. 2008

Schiltenwolf, M / Häuser, W / Felde, E / Flügge, C / Häfner, R / Settan, M / Offenbächer, M. ·Sektion Schmerztherapie, Stiftung Orthopädische Universitätsklinik Heidelberg, Schlierbacher Landstrasse 200, 69118 Heidelberg. Marcus.Schiltenwolf@ok.uni-heidelberg.de · ·Schmerz · Pubmed #18449569.

ABSTRACT: BACKGROUND: A guideline for the treatment and diagnostic procedures for fibromyalgia syndrome (FMS) was developed in cooperation with 10 German medical and psychological associations and 2 patient self-help groups. METHODS: A systematic literature search including all controlled studies evaluating physiotherapy, exercise and strength training as well as physical therapies was performed in the Cochrane Collaboration Reviews (1993-12/2006), Medline (1980-12/2006), PsychInfo (1966-12/2006) and Scopus (1980-12/ 2006). Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. Grading of the strengths of recommendations was done according to the German program for disease management guidelines. Standardized procedures to reach a consensus on recommendations were used. RESULTS: Aerobic exercise training is strongly recommended (grade A) and the temporary use of whole body hyperthermia, balneotherapy and spa therapy is recommended (grade B). CONCLUSION: The significance which can be assigned to most of the studies on the various procedures for therapy is restricted due to short study duration (mean 6-12 weeks) and small sample sizes.

24 Editorial Spondyloarthritis and fibromyalgia: interfering association or differential diagnosis? 2016

Wendling, Daniel / Prati, Clément. ·Department of Rheumatology, CHRU de Besançon, University Teaching Hospital, Boulevard Fleming, F-25030, Besançon, France. dwendling@chu-besancon.fr.; EA4266, Univ. Bourgogne Franche-Comté, 25000, Besançon, France. dwendling@chu-besancon.fr. · Department of Rheumatology, CHRU de Besançon, University Teaching Hospital, Boulevard Fleming, F-25030, Besançon, France.; FDE EA4267, (FHU INCREASE) Univ. Bourgogne Franche-Comté, 25000, Besançon, France. ·Clin Rheumatol · Pubmed #27448150.

ABSTRACT: -- No abstract --

25 Editorial Promoting physical activity in fibromyalgia. 2016

Jones, Kim D. ·Oregon Health & Science University, Portland, OR, USA. ·Pain Manag · Pubmed #27312858.

ABSTRACT: -- No abstract --

Next